Trial Profile
Clinical Trials Insight: 700049292
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2010
Price :
$35
*
At a glance
- Drugs Golimumab (Primary) ; Golimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Centocor
- 27 Sep 2009 New trial record.